Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
St. Jude Children's Research Hospital
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
Baylor College of Medicine